RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $46,000 | -52.6% | 19,996 | -42.4% | 0.00% | – |
| Q1 2021 | $97,000 | -75.4% | 34,688 | -81.5% | 0.00% | -100.0% |
| Q3 2020 | $394,000 | -69.2% | 187,748 | -33.1% | 0.00% | -50.0% |
| Q2 2020 | $1,278,000 | +191.1% | 280,772 | +422.7% | 0.00% | +100.0% |
| Q1 2020 | $439,000 | +10.0% | 53,720 | +146.6% | 0.00% | – |
| Q4 2019 | $399,000 | +110.0% | 21,786 | +27.0% | 0.00% | – |
| Q3 2019 | $190,000 | – | 17,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |